Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Zentek Ltd.NASDAQ: ZTEK

Gross Margin · Q4 FY2025 · quarter ended Mar 2026

Gross margin narrows to -7973.9%

Gross margin was -7973.9% in Q4 FY2025, down 8041.0 pp from a year earlier. On a trailing-twelve-month basis it was -2522.4%, down 2545.1 pp year over year. Over 3 fiscal years it narrowed by 2714.2 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-7973.9%-6016.7 pp QoQ
Last fiscal yearMar 2026
-3785.5%-3807.5 pp YoY
LTMMar 2026
-2522.4%-2545.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8041.0 pp——
1 year-3807.5 pp——
3 years-2714.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
-3785.5%
Year-over-year change
-3807.5pp

Gross Margin vs competitors

How ZTEK compares with its peers on the latest reported figures

  • ZTEK's LTM Mar 2026 gross margin of -2522.4% is the lowest of the 5 companies compared; the peer median is 50.5%.
  • Its year-over-year change of -2545.1 pp is the lowest of 4, against a peer median of +5.4 pp.
  • Over three fiscal years its change of -2714.2 pp compares with a peer median of +11.2 pp.
ZTEK Competitors Peer median
Gross Margin for ZTEK and competitors
Company Period LTM level YoY 3-year change
HYFTMindWalk Holdings Corp.LTM Jan 202660.3% +10.9 pp-1.5 pp
HYPRHyperfine, Inc.LTM Mar 202651.2% +5.0 pp+36.5 pp
AMWLAmerican Well CorporationLTM Mar 202649.7% +5.4 pp+11.2 pp
MBOTMicrobot Medical Inc.LTM Mar 2026-9.5% ——
ZTEKZentek Ltd.LTM Mar 2026-2522.4% -2545.1 pp-2714.2 pp
ALXOALX Oncology Holdings Inc.FY2025— ——
CRDLCardiol Therapeutics Inc.FY2025— ——
GUTSFractyl Health, Inc. Common StockFY2025— ——
BYSIBeyondSpring Inc.FY2025— ——
Peer median (excluding ZTEK) 50.5%+5.4 pp+11.2 pp

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue339.67K72.86K29.82K872.5K166.48K
Cost of Revenue376.79K853.34K331.08K680.01K6.47M
Gross Profit(37.12K)(780.48K)(301.26K)192.49K(6.3M)
Gross Margin-10.9%-1071.3%-1010.4%22.1%-3785.5%
Research & Development1.54M1.65M1.78M465.65K1.66M
Selling, General & Admin9.56M10.99M8.95M8.01M2.87M
Operating Expenses12.53M13.87M11.68M9.79M4.56M
Depreciation & Amortization614.71K539.69K613.71K600.32K527.77K
EBITDA(31.02M)(13.75M)(11.08M)(9.35M)(10.33M)
EBITDA Margin-9131.2%-18878.5%-37170.3%-1071.4%-6204.7%
Operating Income(12.56M)(14.65M)(11.98M)(9.6M)(10.86M)
Operating Margin-3698.5%-20112.5%-40174.8%-1100.4%-6521.7%
Interest Income20.6K510.26K405.48K101.61K40.41K
Interest Expense63.78K120.62K107.37K91.32K289.98K
Other Income / Expenses(19.13M)238.68K174.74K(439.03K)1.06M
Income Before Tax(31.69M)(14.41M)(11.8M)(10.04M)(9.79M)
Pre-Tax Margin-9330.9%-19784.9%-39588.7%-1150.7%-5882.6%
Income Tax Expense00(99.78K)00
Net Income(31.69M)(14.41M)(11.7M)(10.04M)(9.79M)
Net Margin-9330.9%-19784.9%-39254.1%-1150.7%-5882.6%
EPS (Basic)(0.42)(0.14)(0.12)(0.10)(0.09)
EPS (Diluted)(0.42)(0.14)(0.12)(0.10)(0.09)
Weighted Avg Shares92.09M99.44M97.53M102.98M105.92M
Weighted Avg Shares (Diluted)92.09M99.44M100.5M102.98M105.92M

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.